Ignacio Cuervo-Arango

Ignacio Cuervo-Arango is an experienced professional in market access and strategic planning within the pharmaceutical and healthcare sectors. Currently serving as Head of Access Strategic Planning at Novo Nordisk since September 2024, Ignacio previously held several key positions, including Head of Value & Market Access at Galapagos and Market Access & Government Affairs Manager at Roche, focusing on oncology, hematology, and rare diseases. Early career roles included positions at Janssen Pharmaceuticals, IMS Consulting Group, Eli Lilly, and Genesis Pharmaceuticals, covering areas such as health economics, regulatory affairs, and sales. Ignacio holds an M.B.A. from IE Business School and a degree in Pharmacy from Universidad Complutense de Madrid.